Literature DB >> 22740609

Anti-JC-virus antibody prevalence in a German MS cohort.

Clemens Warnke, Thomas Dehmel, Anita Posevitz-Fejfár, Andrew Chan, Achim Berthele, Stephan Schmidt, Judith Haas, Helena C Kronsbein, Florian Seitz, Björn Tackenberg, Mathias Mäurer, Kathrin Gerbershagen, Volker Limmroth, Ortwin Adams, Hans-Peter Hartung, Ralf Gold, Bernhard Hemmer, Heinz Wiendl, Bernd C Kieseier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22740609     DOI： 10.1177/1352458511429955

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  5 in total

1.  Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in Kuwait.

Authors:  R Alroughani; J Al Hashel; A Thussu; S F Ahmed
Journal:  Med Princ Pract       Date:  2013-06-19       Impact factor: 1.927

2.  Smoking is not associated with higher prevalence of JC virus in MS patients.

Authors:  Michael Auer; Gabriel Bsteh; Harald Hegen; Franziska Di Pauli; Sebastian Wurth; Thomas Berger; Florian Deisenhammer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-08       Impact factor: 3.267

3.  Conversion and reversion of anti-John Cunningham virus antibody serostatus: A prospective study.

Authors:  Michael Auer; Harald Hegen; Johann Sellner; Katrin Oppermann; Gabriel Bsteh; Franziska Di Pauli; Thomas Berger; Florian Deisenhammer
Journal:  Brain Behav       Date:  2019-06-06       Impact factor: 2.708

4.  Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients.

Authors:  Ortwin Adams; Marcel Andrée; Denise Rabl; Philipp N Ostermann; Heiner Schaal; Erik Lehnert; Stefanie Ackerstaff; Lisa Müller; Johannes C Fischer
Journal:  J Med Virol       Date:  2021-11-08       Impact factor: 20.693

5.  Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait.

Authors:  S Lamdhade; A Ashkanani; R Alroughani
Journal:  ISRN Neurol       Date:  2014-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.